CN104906450A - 一种治疗胆管炎的中药组合物及其制备方法 - Google Patents
一种治疗胆管炎的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN104906450A CN104906450A CN201510395384.6A CN201510395384A CN104906450A CN 104906450 A CN104906450 A CN 104906450A CN 201510395384 A CN201510395384 A CN 201510395384A CN 104906450 A CN104906450 A CN 104906450A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- cholangitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 239000000203 mixture Substances 0.000 title claims abstract description 54
- 208000003167 cholangitis Diseases 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims description 22
- 241000522620 Scorpio Species 0.000 claims abstract description 31
- 239000009490 scorpio Substances 0.000 claims abstract description 31
- 241000218176 Corydalis Species 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000012634 fragment Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 210000000582 semen Anatomy 0.000 claims description 30
- 239000009636 Huang Qi Substances 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 20
- 239000010231 banlangen Substances 0.000 claims description 20
- 241000287828 Gallus gallus Species 0.000 claims description 19
- 238000009835 boiling Methods 0.000 claims description 19
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 19
- 239000010931 gold Substances 0.000 claims description 19
- 229910052737 gold Inorganic materials 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 11
- 238000010025 steaming Methods 0.000 claims description 11
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000004570 mortar (masonry) Substances 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 239000004576 sand Substances 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 240000007594 Oryza sativa Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 15
- 230000036407 pain Effects 0.000 abstract description 14
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000012528 membrane Substances 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 244000118681 Iresine herbstii Species 0.000 abstract 1
- 241000334160 Isatis Species 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 206010023126 Jaundice Diseases 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 241000209094 Oryza Species 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 210000003445 biliary tract Anatomy 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 210000000013 bile duct Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 201000010312 acute cholangitis Diseases 0.000 description 3
- 201000001352 cholecystitis Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 2
- DPQCZNIGGNJGTD-UHFFFAOYSA-N Chloride-(??)-2-Methylpentanoic acid Natural products CCCCCCC=CCCCCCCCCCC(=O)OC(C)C(C)OC(=O)CCCCCCCC=CCCCCCC DPQCZNIGGNJGTD-UHFFFAOYSA-N 0.000 description 2
- 206010008635 Cholestasis Diseases 0.000 description 2
- DPQCZNIGGNJGTD-MVCBGFDASA-N Coixenolide Chemical compound CCCCCC\C=C\CCCCCCCCCC(=O)O[C@@H](C)[C@@H](C)OC(=O)CCCCCCC\C=C/CCCCCC DPQCZNIGGNJGTD-MVCBGFDASA-N 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 2
- 235000000431 campesterol Nutrition 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 230000007870 cholestasis Effects 0.000 description 2
- 231100000359 cholestasis Toxicity 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010004637 Bile duct stone Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018833 Haematocoele Diseases 0.000 description 1
- 208000005873 Hematocele Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037569 Purulent discharge Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102000004330 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 210000003986 cell retinal photoreceptor Anatomy 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 201000004920 hematocele of tunica vaginalis testis Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N octadec-8-enoic acid Chemical compound CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000004514 sphincter of oddi Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- ZTUXEFFFLOVXQE-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCC(O)=O ZTUXEFFFLOVXQE-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000002417 xiphoid bone Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗胆管炎的中药组合物,取下述重量配比的主要原料制备而成:金钱草5-15份,板蓝根8-17份,薄荷6-12份,大黄5-15份,甘草6-10份,龙骨3-6份,马齿苋10-14份,龙胆草7-13份,鸡肉金8-14份,延胡索3-9份,泽泻4-11份,黄芪9-16份,金银花3-8份,五味子8-15份,薏苡仁2-4份,全蝎0.5-2.5份。该中药组合物对胆管炎效果显著,不仅有消炎、止痛和利尿的功效,还能够根治胆管炎之症,对于久病而致心烦气躁,神情疲乏者有良好的调治作用,本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
Description
技术领域
本发明涉及中医中药领域,尤其是涉及一种治疗胆管炎的中药组合物及其制备方法。
背景技术
胆道炎症以胆管炎症为主者称胆管炎,以胆囊炎症为主者称胆囊炎。两者常同时发生,多是在胆汁淤积的基础上继发细菌感染。细菌可经淋巴道或血道到达胆道,也可从肠道经十二指肠乳头逆行进入胆道。在我国以后者更为常见。可分为急性和慢性两种类型。病因:急性化脓性胆管炎系胆道梗阻(最常见为胆石梗阻)使胆汁淤滞、胆管内压力迅速增高所致胆道急性化脓性感染。急性胆管炎经非手术治疗后,急性炎症得到控制,但胆管内的原发病因(如肝内外胆管结石,胆道蛔虫症或奥狄括约肌狭窄等) 并未解决,胆管内炎症病变转为慢性,使胆管壁增厚。
临床表现:致病菌主要是革兰阴性杆菌,以大肠杆菌最多见。本病起病急剧、凶险,是我国胆石病人死亡的主要原因之一。本病常表现为中上腹不适、胀痛,或呈绞痛发作,进食油腻食物后可加重上腹疼痛,很少有发热和黄疸,腹部体征不明显,可仅有上腹轻压痛,胆囊不肿大。如发生急性发作,则出现腹痛,寒战高热和黄疸等三联征。除有急性胆管炎的Charcot三联症(腹痛、寒战高热、黄疸)外,还有休克、神经中枢系统受抑制表现,称为Reynolds五联征。本病起病常急骤,突然发生剑突下或右上腹剧烈、持续性疼痛。继而出现寒战和弛张型高热,体温可超过40℃。常伴恶心、呕吐、黄疸,但黄疸的深浅与病情的严重性可不一致。近半数病人出现烦躁不安、意识障碍、昏睡乃至昏迷等中枢神经系统抑制表现,同时常有血压下降现象。往往提示病人已发生败血和感染性休克,提示病情危重。
在现有治疗胆管炎症的方法中,授权公告号 CN 103055288 A(申请号 201210587902.0)的专利公开了一种治疗急性胆管炎的中草药组合物,其特征在于由以下重量比的药物组成:柴胡25—30份;黄芩25—30份;板蓝根25—35份;茵陈25—30份;山栀15—20份;金钱草25—35份;胆汁2—4份;京半夏15—25份;枳壳25—30份;生姜10—20份;龙胆草15—20份;红枣25—35 份;竹茹10—20份;郁金25—35份;紫花地丁10—25 份;加水1800份,用砂锅烧开后,文火煎煮20-30分钟,过滤下收取上清液,熬煮3 次,将3 次熬取的上清液混合均匀后装瓶高温灭菌,备用。授权公告号 CN
101612193 B(申请号 200910067324.6)的专利公开了一种用于治疗胆囊炎、胆管炎的药物组合物,其特征在于由如下重量份数比的活性物质制成:穿心莲乙素20-40
份,溪黄草水提物20-35 份,苦木醇提物20-40
份。
上述治疗胆管炎的药物组方简单,效果单一,只能止痛,而不能真正的治疗胆管炎。
发明内容
针对现有治疗胆管炎疗效不足的现状,本发明的目的之一在于提供一种治疗胆管炎的中药组合物,具有易操作、疗效显著的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的上述目的是通过以下技术方案来实现的:
一种治疗胆管炎的中药组合物,取下述重量配比的主要原料制备而成:金钱草5-15份,板蓝根8-17份,薄荷6-12份,大黄5-15份,甘草6-10份,龙骨3-6份,马齿苋10-14份,龙胆草7-13份,鸡肉金8-14份,延胡索3-9份,泽泻4-11份,黄芪9-16份,金银花3-8份,五味子8-15份,薏苡仁2-4份,全蝎0.5-2.5份。
一种治疗胆管炎的中药组合物,更加优选的方案,取下述重量配比的主要原料制备而成:金钱草8-13份,板蓝根12-14份,薄荷8-10份,大黄8-13份,甘草7-9份,龙骨4-5份,马齿苋11-13份,龙胆草9-11份,鸡肉金10-12份,延胡索5-7份,泽泻6-9份,黄芪11-15份,金银花4-7份,五味子10-13份,薏苡仁2.5-3.5份,全蝎1-2份。
一种治疗胆管炎的中药组合物,最佳的方案,取下述重量配比的主要原料制备而成:金钱草11份,板蓝根13份,薄荷9份,大黄12份,甘草8份,龙骨4.5份,马齿苋12份,龙胆草10份,鸡肉金11份,延胡索6份,泽泻7.5份,黄芪13份,金银花5份,五味子11.5份,薏苡仁3份,全蝎1.5份。
上述中药组合物的制备步骤如下:
①将全蝎置于瓦罐内,取全蝎重量1-3倍的白酒,浸泡5-9日,取出置于炉火上,烤制酥脆,研磨成细末待用;
②将薏苡仁用清水洗净,放入砂煲内,加薏苡仁重量2-4倍的清水,武火煮沸后,改用文火煲60-80分钟,过滤,滤液待用;
③将龙骨用铁丝拴住,置于炉火上烤制酥脆,研碎待用;
④将金钱草、板蓝根、薄荷、大黄、黄芪和金银花除去杂质,洗净,用米醋润透,切薄片或者切丝,置于蒸笼上,待水沸后,转文火蒸煮10-20分钟,将过烧热,放入蒸煮好的原料药,炒120-180秒,晾凉研磨成细末过80-120目筛待用;
⑤将甘草、马齿苋、龙胆草、鸡肉金、延胡索、泽泻和五味子清洗干净,用温水浸泡30-40分钟,切成小块,置于研钵内,使劲研磨成碎块,置于容器内,加入清水,浸泡2-4小时,过滤,滤液待用;
⑥将步骤①-⑤所得物混匀放入砂锅内,用木棍搅拌均匀,置于无烟的炉火上小火加热至沸腾,待沸腾60-80秒后转小火煎煮并且不断搅拌成稠膏,放凉至室温,装瓶即得中药组合物。
上述中药组合物的制备方法,步骤①取全蝎重量1.5-2.5倍的白酒,浸泡6-8日(优选的,取全蝎重量2倍的白酒,浸泡7日)。
上述中药组合物的制备方法,步骤②加薏苡仁重量2.5-3.5倍的清水,武火煮沸后,改用文火煲65-75分钟(优选的,加薏苡仁重量3倍的清水,武火煮沸后,改用文火煲70分钟)。
上述中药组合物的制备方法,步骤④待水沸后,转文火蒸煮13-18分钟,将过烧热,放入蒸煮好的原料药,炒140-160秒(优选的,待水沸后,转文火蒸煮15分钟,将过烧热,放入蒸煮好的原料药,炒150秒)。
上述中药组合物的制备方法,步骤⑤用温水浸泡33-38分钟(优选的,用温水浸泡35分钟)。
上述中药组合物的制备方法,步骤⑤浸泡2.5-3.5小时,过滤(优选的,浸泡3小时,过滤)。
上述中药组合物的制备方法,步骤⑥待沸腾65-75秒后转小火煎煮并且不断搅拌成稠膏(优选的,待沸腾70秒后转小火煎煮并且不断搅拌成稠膏)。
使用方法:为使本发明中药组合物达到最佳治疗效果,使用时,将稠膏置于干净的容器内,用热水稀释,可适当放入白糖,晾凉口服即可,5天为一个疗程。
该中药组合物对胆管炎效果显著,不仅有消炎、止痛和利尿的功效,还能够根治胆管炎之症,对于久病而致心烦气躁,神情疲乏者有良好的调治作用,本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
各原料药的药理功效分别为:
五味子:敛肺,滋肾,生津,收汗,涩精。治肺虚喘咳,口干作渴,自汗,盗汗,劳伤羸瘦,梦遗滑精,久泻久痢,明目,暖水脏,治风,下气,消食,霍乱转筋,痃癖奔豚冷气,消水肿,反胃,心腹气胀,止渴,除烦热,解酒毒,壮筋骨。
金钱草:味甘、微苦、性凉。归肝、胆、肾、膀胱经。功效主治编辑金钱草是一种常见植物,而且是一种中药材,他主要功效就是可以预防结石和利胆排石可以说对结石有非常好治疗和预防作用,利水通淋;清热解毒;散瘀消肿,清利湿热,沙淋,尿涩作痛,黄疸尿赤,痈肿疔疮,主治肝胆及泌尿系结石;热淋;肾炎水肿;湿热黄疸;疮毒痈肿;毒蛇咬伤;跌打损伤。
黄芪:现代医学研究表明,黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿,增强心肌收缩力,调节血糖含量。黄芪不仅能扩张冠状动脉,改善心肌供血,提高免疫功能,而且能够延缓细胞衰老的进程。黄芪食用方便,可煎汤,煎膏,浸酒,入菜肴等。
板蓝根:其性寒,味先微甜后苦涩,具有清热解毒、预防感冒、利咽之功效。主要用于治疗温毒发斑、舌绛紫暗、烂喉丹痧等疾病。
薄荷:它是辛凉性发汗解热药,治流行性感冒、头疼、目赤、身热、咽喉、牙床肿痛等症。外用可治神经痛、皮肤瘙痒、皮疹和湿疹等。光朋温室采摘的薄荷又是春节餐桌上的鲜菜。清爽可口。平常以薄荷代茶,清心明目。
大黄:归心、肝、脾经。功效活血行气止痛,消肿生肌。主治用于胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,症瘕腹痛,风湿痹痛,筋脉拘挛,跌打损伤,痈肿疮疡。
甘草:甘草专泄胃实,开导坚结,故主中脘以治血分,疗脐腹间实满,消痰癖,祛停水,逐宿食,破结胸,通便闭,非此不能也。若皮肤作痒,因积血滞于中,不能营养肌表,若饮食不思,因脾郁结不能运化,皆取其辛散苦泻之力也。为血分中之气药,惟此称最。
龙骨:化石,通淋,消炎。治石淋,小便不利,中耳炎,鼻炎,脑漏。研末或烧研水服,主淋沥、小便不通。
马齿苋:该种为药食两用植物。全草供药用,有清热利湿、解毒消肿、消炎、止渴、利尿作用;种子明目。现代研究,马齿苋还含有丰富的SL3脂肪酸及维生素A样物质。SL3脂肪酸是形成细胞膜,尤其是脑细胞膜与眼细胞膜所必需的物质;维生素A样物质能维持上皮组织如皮肤、角膜及结合膜的正常机能,参与视紫质的合成,增强视网膜感光性能,也参与体内许多氧化过程。
龙胆草:具有利湿退黄,清热解毒,散瘀止痛,止咳化痰的功效。用于湿热黄疸,淋浊,带下,风湿痹痛,痈肿疮毒,水火烫伤,经闭,症瘕,趺打损伤,肺热咳嗽。
鸡肉金:消积滞,健脾胃。治食积胀满,呕吐反胃,泻痢,疳积,消渴,遗溺,喉痹乳蛾,牙疳口疮。
延胡索:性味:辛;苦;温;无毒。归经:肝;胃;心;肺;脾经。主治:活血;散瘀;理气;止痛。主心腹腰膝诸痛;月经不调;症瘕;崩中;产后血晕;恶露不尽;跌打损伤。
泽泻:功效:行气,止痛,健脾,消食主治:行气止痛;调中导滞。主胞胁胀满足 ;脘腹胀痛;嗳吐泄泻;痢疾后重。用于胸脘胀痛、泻痢后重、食积不消、不思饮食;中气不省;突发耳聋;蛇虫咬伤;牙痛。
金银花:金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
薏苡仁:含薏苡仁酯(coixenolide);并含脂肪油,油中含肉豆蔻酸(myristic
acid)、芸苔甾醇(campesterol)、棕榈酸、8-十八烯酸、豆甾醇等,尚含氨基酸、蛋白质、糖类。
性味 性凉,味甘、淡。健脾,渗湿,止泻,排脓。用于脾虚腹泻,肌肉酸重,关节疼痛,水肿,脚气,白带,肺脓疡,阑尾炎。常用量9~30克。利湿健脾;舒筋除痹;清热排脓。
全蝎:辛,平。归经归肝经。功效息风镇痉,通络止痛,攻毒散结。主治用于肝风内动,痉挛抽搐,小儿惊风,中风口㖞,半身不遂,破伤风,风湿顽痹,偏正头痛,疮疡,瘰疬。
本发明中药组合物基于中医中药治疗胆管炎的原理,选用的药材均有止痛通络的功效,针对胆管炎辨证施治,属于标本兼治的组方,对胆管炎有极好的治疗作用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例 1:一种治疗胆管炎的中药组合物,取下述重量配比的主要原料制备而成(每份取10g):金钱草5份,板蓝根8份,薄荷6份,大黄5份,甘草6份,龙骨3份,马齿苋10份,龙胆草7份,鸡肉金8份,延胡索3份,泽泻4份,黄芪9份,金银花3份,五味子8份,薏苡仁2份,全蝎0.5份。
上述治疗胆管炎的中药组合物的制备方法,步骤如下:
①将全蝎置于瓦罐内,取全蝎重量1倍的白酒,浸泡5日,取出置于炉火上,烤制酥脆,研磨成细末待用;
②将薏苡仁用清水洗净,放入砂煲内,加薏苡仁重量2倍的清水,武火煮沸后,改用文火煲60分钟,过滤,滤液待用;
③将龙骨用铁丝拴住,置于炉火上烤制酥脆,研碎待用;
④将金钱草、板蓝根、薄荷、大黄、黄芪和金银花除去杂质,洗净,用米醋润透,切薄片或者切丝,置于蒸笼上,待水沸后,转文火蒸煮10分钟,将过烧热,放入蒸煮好的原料药,炒120秒,晾凉研磨成细末过80目筛待用;
⑤将甘草、马齿苋、龙胆草、鸡肉金、延胡索、泽泻和五味子清洗干净,用温水浸泡30分钟,切成小块,置于研钵内,使劲研磨成碎块,置于容器内,加入清水,浸泡2小时,过滤,滤液待用;
⑥将步骤①-⑤所得物混匀放入砂锅内,用木棍搅拌均匀,置于无烟的炉火上小火加热至沸腾,待沸腾60秒后转小火煎煮并且不断搅拌成稠膏,放凉至室温,装瓶即得中药组合物。
实施例 2:一种治疗胆管炎的中药组合物,取下述重量配比的主要原料制备而成(每份取10g):金钱草15份,板蓝根17份,薄荷12份,大黄15份,甘草10份,龙骨6份,马齿苋14份,龙胆草13份,鸡肉金14份,延胡索9份,泽泻11份,黄芪16份,金银花8份,五味子15份,薏苡仁4份,全蝎2.5份。
上述治疗胆管炎的中药组合物的制备方法,步骤如下:
①将全蝎置于瓦罐内,取全蝎重量3倍的白酒,浸泡9日,取出置于炉火上,烤制酥脆,研磨成细末待用;
②将薏苡仁用清水洗净,放入砂煲内,加薏苡仁重量4倍的清水,武火煮沸后,改用文火煲80分钟,过滤,滤液待用;
③将龙骨用铁丝拴住,置于炉火上烤制酥脆,研碎待用;
④将金钱草、板蓝根、薄荷、大黄、黄芪和金银花除去杂质,洗净,用米醋润透,切薄片或者切丝,置于蒸笼上,待水沸后,转文火蒸煮20分钟,将过烧热,放入蒸煮好的原料药,炒180秒,晾凉研磨成细末过120目筛待用;
⑤将甘草、马齿苋、龙胆草、鸡肉金、延胡索、泽泻和五味子清洗干净,用温水浸泡40分钟,切成小块,置于研钵内,使劲研磨成碎块,置于容器内,加入清水,浸泡4小时,过滤,滤液待用;
⑥将步骤①-⑤所得物混匀放入砂锅内,用木棍搅拌均匀,置于无烟的炉火上小火加热至沸腾,待沸腾80秒后转小火煎煮并且不断搅拌成稠膏,放凉至室温,装瓶即得中药组合物。
实施例 3 :一种治疗胆管炎的中药组合物,取下述重量配比的主要原料制备而成(每份取10g):金钱草8份,板蓝根12份,薄荷8份,大黄8份,甘草7份,龙骨4份,马齿苋11份,龙胆草9份,鸡肉金10份,延胡索5份,泽泻6份,黄芪11份,金银花4份,五味子10份,薏苡仁2.5份,全蝎1份。
上述治疗胆管炎的中药组合物的制备方法,步骤如下:
①将全蝎置于瓦罐内,取全蝎重量1.5倍的白酒,浸泡6日,取出置于炉火上,烤制酥脆,研磨成细末待用;
②将薏苡仁用清水洗净,放入砂煲内,加薏苡仁重量2.5倍的清水,武火煮沸后,改用文火煲65分钟,过滤,滤液待用;
③将龙骨用铁丝拴住,置于炉火上烤制酥脆,研碎待用;
④将金钱草、板蓝根、薄荷、大黄、黄芪和金银花除去杂质,洗净,用米醋润透,切薄片或者切丝,置于蒸笼上,待水沸后,转文火蒸煮13分钟,将过烧热,放入蒸煮好的原料药,炒140秒,晾凉研磨成细末过90目筛待用;
⑤将甘草、马齿苋、龙胆草、鸡肉金、延胡索、泽泻和五味子清洗干净,用温水浸泡33分钟,切成小块,置于研钵内,使劲研磨成碎块,置于容器内,加入清水,浸泡2.5小时,过滤,滤液待用;
⑥将步骤①-⑤所得物混匀放入砂锅内,用木棍搅拌均匀,置于无烟的炉火上小火加热至沸腾,待沸腾65秒后转小火煎煮并且不断搅拌成稠膏,放凉至室温,装瓶即得中药组合物。
实施例 4 :一种治疗胆管炎的中药组合物,取下述重量配比的主要原料制备而成(每份取10g):金钱草13份,板蓝根14份,薄荷10份,大黄13份,甘草9份,龙骨5份,马齿苋13份,龙胆草11份,鸡肉金12份,延胡索7份,泽泻9份,黄芪15份,金银花7份,五味子13份,薏苡仁3.5份,全蝎2份。
上述治疗胆管炎的中药组合物的制备方法,步骤如下:
①将全蝎置于瓦罐内,取全蝎重量2.5倍的白酒,浸泡8日,取出置于炉火上,烤制酥脆,研磨成细末待用;
②将薏苡仁用清水洗净,放入砂煲内,加薏苡仁重量3.5倍的清水,武火煮沸后,改用文火煲75分钟,过滤,滤液待用;
③将龙骨用铁丝拴住,置于炉火上烤制酥脆,研碎待用;
④将金钱草、板蓝根、薄荷、大黄、黄芪和金银花除去杂质,洗净,用米醋润透,切薄片或者切丝,置于蒸笼上,待水沸后,转文火蒸煮18分钟,将过烧热,放入蒸煮好的原料药,炒160秒,晾凉研磨成细末过110目筛待用;
⑤将甘草、马齿苋、龙胆草、鸡肉金、延胡索、泽泻和五味子清洗干净,用温水浸泡38分钟,切成小块,置于研钵内,使劲研磨成碎块,置于容器内,加入清水,浸泡3.5小时,过滤,滤液待用;
⑥将步骤①-⑤所得物混匀放入砂锅内,用木棍搅拌均匀,置于无烟的炉火上小火加热至沸腾,待沸腾75秒后转小火煎煮并且不断搅拌成稠膏,放凉至室温,装瓶即得中药组合物。
实施例 5 :一种治疗胆管炎的中药组合物,取下述重量配比的主要原料制备而成(每份取10g):金钱草11份,板蓝根13份,薄荷9份,大黄12份,甘草8份,龙骨4.5份,马齿苋12份,龙胆草10份,鸡肉金11份,延胡索6份,泽泻7.5份,黄芪13份,金银花5份,五味子11.5份,薏苡仁3份,全蝎1.5份。
上述治疗胆管炎的中药组合物的制备方法,步骤如下:
①将全蝎置于瓦罐内,取全蝎重量2倍的白酒,浸泡7日,取出置于炉火上,烤制酥脆,研磨成细末待用;
②将薏苡仁用清水洗净,放入砂煲内,加薏苡仁重量3倍的清水,武火煮沸后,改用文火煲70分钟,过滤,滤液待用;
③将龙骨用铁丝拴住,置于炉火上烤制酥脆,研碎待用;
④将金钱草、板蓝根、薄荷、大黄、黄芪和金银花除去杂质,洗净,用米醋润透,切薄片或者切丝,置于蒸笼上,待水沸后,转文火蒸煮15分钟,将过烧热,放入蒸煮好的原料药,炒150秒,晾凉研磨成细末过100目筛待用;
⑤将甘草、马齿苋、龙胆草、鸡肉金、延胡索、泽泻和五味子清洗干净,用温水浸泡35分钟,切成小块,置于研钵内,使劲研磨成碎块,置于容器内,加入清水,浸泡3小时,过滤,滤液待用;
⑥将步骤①-⑤所得物混匀放入砂锅内,用木棍搅拌均匀,置于无烟的炉火上小火加热至沸腾,待沸腾70秒后转小火煎煮并且不断搅拌成稠膏,放凉至室温,装瓶即得中药组合物。
实验例一:为了验证本发明中药组合物(实施例5)的效果,我们抽取了400名患者进行了药物的实验,分为实验组及对照组,实验组服用实施例5所得中药组合物,对照组服用其它治疗胆管炎的中药与西药药品。
入选标准:经确诊为胆管炎患者,有胆管炎临床症状一项或多项。
疗效情况判定标准:1、治愈。服用药物后,不适症状完全消失;2、有效。服用药物后,不适症状减轻或部分消失;3、无效。服用药物后,不适症状无变化。
表1:两组临床疗效比较【例】表1
表1
本发明中药组合物与其它治疗胆管炎的药物相比治愈率高,总有效率为99%,效果明显优于对照组,该发明的中药组合物造价低廉,普通百姓长期使用,也不会增加身体和金钱上的负担。临床实验中未出现一例副作用情况,安全性远高于治疗胆管炎的同类中西药物,且见效快,使胆管炎的治愈不再是可求而不可得的,是目前治疗胆管炎最为理想安全的中药组合物。
Claims (10)
1.一种治疗胆管炎的中药组合物,其特征在于:取下述重量配比的主要原料制备而成:金钱草5-15份,板蓝根8-17份,薄荷6-12份,大黄5-15份,甘草6-10份,龙骨3-6份,马齿苋10-14份,龙胆草7-13份,鸡肉金8-14份,延胡索3-9份,泽泻4-11份,黄芪9-16份,金银花3-8份,五味子8-15份,薏苡仁2-4份,全蝎0.5-2.5份。
2.根据权利要求1所述的治疗胆管炎的中药组合物,其特征在于:取下述重量配比的主要原料制备而成:金钱草8-13份,板蓝根12-14份,薄荷8-10份,大黄8-13份,甘草7-9份,龙骨4-5份,马齿苋11-13份,龙胆草9-11份,鸡肉金10-12份,延胡索5-7份,泽泻6-9份,黄芪11-15份,金银花4-7份,五味子10-13份,薏苡仁2.5-3.5份,全蝎1-2份。
3.根据权利要求1所述的治疗胆管炎的中药组合物,其特征在于:取下述重量配比的主要原料制备而成:金钱草11份,板蓝根13份,薄荷9份,大黄12份,甘草8份,龙骨4.5份,马齿苋12份,龙胆草10份,鸡肉金11份,延胡索6份,泽泻7.5份,黄芪13份,金银花5份,五味子11.5份,薏苡仁3份,全蝎1.5份。
4.根据权利要求1-3任一项所述的治疗胆管炎的中药组合物的制备方法,其特征在于:步骤如下:
①将全蝎置于瓦罐内,取全蝎重量1-3倍的白酒,浸泡5-9日,取出置于炉火上,烤制酥脆,研磨成细末待用;
②将薏苡仁用清水洗净,放入砂煲内,加薏苡仁重量2-4倍的清水,武火煮沸后,改用文火煲60-80分钟,过滤,滤液待用;
③将龙骨用铁丝拴住,置于炉火上烤制酥脆,研碎待用;
④将金钱草、板蓝根、薄荷、大黄、黄芪和金银花除去杂质,洗净,用米醋润透,切薄片或者切丝,置于蒸笼上,待水沸后,转文火蒸煮10-20分钟,将过烧热,放入蒸煮好的原料药,炒120-180秒,晾凉研磨成细末过80-120目筛待用;
⑤将甘草、马齿苋、龙胆草、鸡肉金、延胡索、泽泻和五味子清洗干净,用温水浸泡30-40分钟,切成小块,置于研钵内,使劲研磨成碎块,置于容器内,加人清水,浸泡2-4小时,过滤,滤液待用;
⑥将步骤①-⑤所得物混匀放入砂锅内,用木棍搅拌均匀,置于无烟的炉火上小火加热至沸腾,待沸腾60-80秒后转小火煎煮并且不断搅拌成稠膏,放凉至室温,装瓶即得中药组合物。
5.根据权利要求4所述的中药组合物的制备方法,其特征在于:步骤①取全蝎重量1.5-2.5倍的白酒,浸泡6-8日(优选的,取全蝎重量2倍的白酒,浸泡7日)。
6.根据权利要求4所述的中药组合物的制备方法,其特征在于:步骤②加薏苡仁重量2.5-3.5倍的清水,武火煮沸后,改用文火煲65-75分钟(优选的,加薏苡仁重量3倍的清水,武火煮沸后,改用文火煲70分钟)。
7.根据权利要求4所述的中药组合物的制备方法,其特征在于:步骤④待水沸后,转文火蒸煮13-18分钟,将过烧热,放入蒸煮好的原料药,炒140-160秒(优选的,待水沸后,转文火蒸煮15分钟,将过烧热,放入蒸煮好的原料药,炒150秒)。
8.根据权利要求4所述的中药组合物的制备方法,其特征在于:步骤⑤用温水浸泡33-38分钟(优选的,用温水浸泡35分钟)。
9.根据权利要求4所述的中药组合物的制备方法,其特征在于:步骤⑤浸泡2.5-3.5小时,过滤(优选的,浸泡3小时,过滤)。
10.根据权利要求4所述的中药组合物的制备方法,其特征在于:步骤⑥待沸腾65-75秒后转小火煎煮并且不断搅拌成稠膏(优选的,待沸腾70秒后转小火煎煮并且不断搅拌成稠膏)。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510395384.6A CN104906450A (zh) | 2015-07-08 | 2015-07-08 | 一种治疗胆管炎的中药组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510395384.6A CN104906450A (zh) | 2015-07-08 | 2015-07-08 | 一种治疗胆管炎的中药组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104906450A true CN104906450A (zh) | 2015-09-16 |
Family
ID=54076166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510395384.6A Pending CN104906450A (zh) | 2015-07-08 | 2015-07-08 | 一种治疗胆管炎的中药组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104906450A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1368165A (zh) * | 2001-02-05 | 2002-09-11 | 杨孟君 | 纳米舒胆制剂药物及其制备方法 |
-
2015
- 2015-07-08 CN CN201510395384.6A patent/CN104906450A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1368165A (zh) * | 2001-02-05 | 2002-09-11 | 杨孟君 | 纳米舒胆制剂药物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| 洪文旭等: "《实用中医消化病学》", 31 December 1994, 天津科技翻译出版公司出版 * |
| 范文昌等: "《广东地产清热解毒药物大全》", 31 July 2011, 中医古籍出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105030935A (zh) | 一种治疗下肢静脉曲张的中药外敷制剂及其制备方法 | |
| CN103861014A (zh) | 一种治疗慢性胃炎的中药口服液 | |
| CN104740211A (zh) | 一种治疗下肢静脉曲张的中药组合物及其制备方法 | |
| CN102973754B (zh) | 一种有效治疗胞生痰核病的中药组合物 | |
| CN103816450B (zh) | 一种治疗类风湿性关节炎的中药 | |
| CN104740227A (zh) | 治疗小儿泄泻的中药制剂 | |
| CN105031563A (zh) | 化淤酒 | |
| CN104940728A (zh) | 一种治疗胆管结石与胆管炎的中药组合物及其制备方法 | |
| CN104906450A (zh) | 一种治疗胆管炎的中药组合物及其制备方法 | |
| CN103417669B (zh) | 一种治疗腹痛、腹泻的药物 | |
| CN103705614B (zh) | 一种治疗带状疱疹的中药 | |
| CN102327440A (zh) | 治疗流注的中草药 | |
| CN109276687A (zh) | 一种补气活血药酒及其制备方法 | |
| CN108721540A (zh) | 治疗肝癌六种情况的中药配方 | |
| CN105031519A (zh) | 一种治疗关节炎的中药外敷制剂及其制备方法 | |
| CN104998131A (zh) | 可用于促进伤骨愈合的组合物及其制备方法 | |
| CN105412830A (zh) | 一种治疗急性黄疸型肝炎的药物及其制备方法 | |
| CN104887841A (zh) | 治疗痛风的中药制剂 | |
| CN104888148A (zh) | 一种治疗慢性乙型肝炎的药物 | |
| CN104435878A (zh) | 治疗传染性湿疹样皮炎的中药制剂 | |
| CN104740478A (zh) | 一种用于急诊处理酒精中毒征的中药丸剂及制备方法 | |
| CN102366474A (zh) | 治疗牙龈炎的中草药 | |
| CN102327439A (zh) | 治疗败血症的中草药 | |
| CN102327418A (zh) | 治疗腰肌劳损的中草药 | |
| CN107596067A (zh) | 一种治疗气滞血瘀证肠结核的汤剂药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150916 |
|
| RJ01 | Rejection of invention patent application after publication |